首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷內視鏡檢查設備

市場調查報告書

商品編碼

1606511

全球軟性內視鏡市場 - 2024-2031

Global Flexible Endoscopy Market - 2024-2031

出版日期: 2024年12月04日 | 出版商:

DataM Intelligence | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

2023年，全球軟性內視鏡市場規模達到75.6億美元，預計2031年將達到117.3億美元，2024-2031年預測期間複合年成長率為5.7%。

軟性內視鏡檢查是一種醫療程序，涉及使用稱為內視鏡的軟性長而細的管子來目視檢查身體的內部器官和腔體。這項技術允許醫療保健專業人員診斷、治療或監測各種病症，而無需大切口，使其成為一種微創手術。內視鏡配備光源、攝影機，有時還配備儀器通道以進行干預。與傳統手術不同，軟性內視鏡手術切口較小或根本沒有切口，從而減少了患者的風險、疼痛和恢復時間。

受慢性病發病率增加、內視鏡技術進步、微創手術的日益採用以及全球醫療保健意識不斷提高等因素的推動，軟性內視鏡市場正在經歷各種醫學專業的巨大需求。胃腸道疾病，包括大腸直腸癌、發炎性腸道疾病（IBD）和胃食道逆流（GERD），是軟性內視鏡需求的主要驅動力。例如，根據美國國立衛生研究院的說法，透過診斷和管理，內視鏡檢查在幾乎所有胃腸道疾病中都發揮作用。據估計，美國每年進行超過 2,000 萬次胃腸道內視鏡檢查。

市場動態：

驅動程式和限制

人們越來越偏好微創手術

對微創手術日益成長的偏好極大地推動了軟性內視鏡市場的成長，預計將在預測期內推動該市場的發展。使用軟性內視鏡進行的微創手術需要較小的切口或根本不需要切口，對身體造成的創傷較小。與傳統手術相比，這可以使患者恢復更快並減少疼痛。

例如，在結腸鏡檢查中，該過程涉及透過直腸插入軟性內視鏡。與接受結腸癌診斷的開放手術相比，患者通常恢復得更快，不適也更少。

軟性內視鏡擴大用於癌症篩檢，例如大腸直腸癌的大腸鏡檢查，這是微創手術的關鍵應用。早期發現並去除癌前生長物可以減少以後對更具侵入性的治療的需要，使軟性內視鏡檢查成為首選。

例如，根據世界癌症研究基金會的數據，2022 年有 1,926,425 例大腸直腸癌新病例。透過大腸鏡檢查進行篩檢可以及早發現並切除息肉，因此無需進行更具侵入性的治療。

軟式內視鏡費用高

軟性內視鏡的高成本是阻礙軟性內視鏡市場成長的一個重要因素，因為它給醫療保健提供者和患者都帶來了挑戰。這些成本的幾個方面，包括設備購買、維護和手術費用，影響內視鏡手術的可及性和可負擔性，限制了其廣泛採用。

軟性內視鏡是複雜的設備，需要高品質的組件，例如高清攝影機、光纖電纜、光源和先進的影像處理系統。這些功能導致內視鏡設備的購買成本較高，具體取決於規格。例如，據波士頓科學公司稱，再處理一台軟性內視鏡的總成本為 114.07 美元至 280.71 美元。

Flexible endoscopy is a medical procedure that involves the use of a flexible, long and thin tube known as an endoscope to visually examine the internal organs and cavities of the body. This technique allows healthcare professionals to diagnose, treat or monitor various conditions without the need for large incisions, making it a form of minimally invasive surgery. The endoscope is equipped with a light source, a camera and sometimes instrument channels to perform interventions. Unlike traditional surgery, flexible endoscopy involves smaller incisions or no incisions at all, reducing risks, pain and recovery time for patients.

The flexible endoscopy market is experiencing significant demand across a variety of medical specialties, driven by factors such as increasing incidence of chronic diseases, advancements in endoscopic technology, growing adoption of minimally invasive procedures and rising healthcare awareness globally. GI disorders, including colorectal cancer, inflammatory bowel disease (IBD) and gastroesophageal reflux disease (GERD), are major drivers for the demand for flexible endoscopy. For instance, according to the NIH, through diagnosis and management, endoscopy plays a role in nearly all GI diseases. It is estimated that more than 20 million GI endoscopies are performed yearly in the United States.

Market Dynamics: Drivers & Restraints

Growing preference for minimally invasive procedures

Growing preference for minimally invasive procedures is significantly driving the growth of the flexible endoscopy market and is expected to drive the market over the forecast period. Minimally invasive procedures performed using flexible endoscopes require smaller incisions or no incisions at all, resulting in less trauma to the body. This leads to faster recovery and reduced pain for patients compared to traditional surgeries.

For instance, in colonoscopy, the procedure involves a flexible endoscope inserted through the rectum. Patients typically recover much faster and with less discomfort than if they underwent an open surgery for colon cancer diagnosis.

The flexible endoscope is increasingly used in cancer screening, such as colonoscopy for colorectal cancer, which is a key application of minimally invasive procedures. Early detection and removal of precancerous growths reduce the need for more invasive treatments later on, making flexible endoscopy a preferred choice.

For instance, according to the World Cancer Research Fund, there were 1,926,425 new cases of colorectal cancer in 2022. Colorectal cancer is one of the most common cancers worldwide. Screening with colonoscopy allows for early detection and polyp removal, preventing the need for more invasive treatments.

High cost of flexible endoscopy

The high cost of flexible endoscopy is a significant factor hampering the growth of the flexible endoscopy market, as it presents challenges for both healthcare providers and patients. Several aspects of these costs including equipment purchase, maintenance and procedural expenses impact the accessibility and affordability of endoscopic procedures, limiting their widespread adoption.

Flexible endoscopes are sophisticated devices that require high-quality components, such as high-definition cameras, fiber-optic cables, light sources and advanced image processing systems. These features contribute to the high purchase cost of endoscopy equipment, depending on the specifications. For instance, according to Boston Scientific, the overall cost of reprocessing one flexible endoscope ranged from $114.07 to $280.71.

Segment Analysis

The global flexible endoscopy market is segmented based on product type, application, end-user and region.

Application:

The gastroenterology segment is expected to dominate the global flexible endoscopy market share

The gastroenterology segment holds a major portion of the flexible endoscopy market share and is expected to continue to hold a significant portion of the market share over the forecast period primarily driven by the high prevalence of gastrointestinal (GI) disorders, the increasing demand for early detection and screening of GI diseases and the use of minimally invasive procedures for both diagnostic and therapeutic purposes.

Gastrointestinal disorders, including colorectal cancer, irritable bowel syndrome (IBS), gastroesophageal reflux disease (GERD), and inflammatory bowel disease (IBD) are widespread globally. Flexible endoscopy plays a crucial role in diagnosing and managing these conditions, making gastroenterology the largest segment in the market.

For instance, according to the World Gastroenterology Organisation, While GI diseases remained very common (incidence 7.3 billion cases - largely due to enteric infections) and important (8 million deaths - cirrhosis a major factor) prevalence remained stable. Overall, 49% of females and 36.6% of males met the criteria for at least one functional gastrointestinal disorder - the most common disorders in all regions being functional constipation, functional dyspepsia, proctalgia fugax, functional diarrhea and IBS at prevalence rates of 11.7%, 7.2%, 5.9%, 4.7% and 4.1, respectively.

Additionally, Colorectal cancer (CRC) is one of the most common cancers worldwide, with about 1,926,425 new cases of colorectal cancer in 2022, and colonoscopy remains the gold standard for early detection. Flexible sigmoidoscopy and colonoscopy are key procedures used in the diagnosis and prevention of colorectal cancer.

North America is expected to hold a significant position in the global flexible endoscopy market

North America region is expected to hold the largest market share over the forecast period. North America, particularly the United States, is known for its state-of-the-art healthcare infrastructure, which includes hospitals, clinics and diagnostic centers equipped with the latest medical technologies, including advanced flexible endoscopes. The widespread adoption of high-definition flexible endoscopes, AI-assisted colonoscopy systems and robotic-assisted endoscopy technologies has significantly enhanced the accuracy and efficacy of endoscopic procedures in North America.

North America has some of the highest healthcare spending globally, particularly in the United States. For instance, according to the U.S. Centers for Medicare & Medicaid Services, U.S. healthcare spending grew 4.1 percent in 2022, reaching $4.5 trillion or $13,493 per person. As a share of the nation's Gross Domestic Product, health spending accounted for 17.3 percent. This high spending allows for the procurement of advanced medical devices, including flexible endoscopes.

North America has well-established cancer screening programs, particularly for colorectal cancer. The U.S. Preventive Services Task Force and other healthcare bodies recommend regular colonoscopy screenings for individuals over the age of 50. These screenings contribute significantly to the volume of flexible endoscopy procedures performed in the region.

For instance, according to the National Institute of Health, in the United States, the most commonly used colorectal cancer screening test was colonoscopy, with an estimated 61% of adults aged 50-75 years reporting colonoscopy use within the past 10 years, further fueling the demand for flexible endoscopy in the region.

Asia Pacific is growing at the fastest pace in the flexible endoscopy market

The Asia Pacific region is experiencing the fastest growth in the flexible endoscopy market. The prevalence of gastrointestinal diseases such as colorectal cancer (CRC), gastroesophageal reflux disease (GERD) and inflammatory bowel diseases (IBD) is rising in the Asia Pacific region, leading to an increased demand for flexible endoscopic procedures.

For instance, in China, colorectal cancer is also one of the most commonly diagnosed cancers. A recent study showed that colorectal cancer ranks second in incidence and fourth in mortality, with 408,000 cases and 196,000 deaths, and remains a major public health problem, this growing incidence of GI cancers drives demand for early detection through colonoscopy and other endoscopic procedures.

Competitive Landscape

The major global players in the flexible endoscopy market Becton, Dickinson and Company, KARL STORZ, Olympus Corporation, FUJIFILM Holdings Corporation, Boston Scientific Corporation, Richard Wolf GmbH, ATMOS MedizinTechnik GmbH & Co. KG, LABORIE MEDICAL TECHNOLOGIES CORP., EndoMed Systems GmbH, Entermed and among others.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global flexible endoscopy market report would provide approximately 62 tables, 53 figures and 197 pages.

Target Audience 2023

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Application
3.3. Snippet by End-User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Growing Preference for Minimally Invasive Procedures
  - 4.1.1.2. Technological Advancements in Endoscopic Systems
- 4.1.2. Restraints
  - 4.1.2.1. High Cost of Flexible Endoscopy
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Patent Analysis
5.5. Regulatory Analysis
5.6. SWOT Analysis
5.7. Unmet Needs

6. By Product Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 6.1.2. Market Attractiveness Index, By Product Type
6.2. Gastroscopes*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Colonoscopes
6.4. Enteroscopes
6.5. Duodenoscopes
6.6. Bronchoscopes
6.7. Echoendoscopes
6.8. Others

7. By Application

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 7.1.2. Market Attractiveness Index, By Application
7.2. Gastroenterology*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Pulmonology
7.4. Gynecology
7.5. Urology
7.6. Others

8. By End-User

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 8.1.2. Market Attractiveness Index, By End-User
8.2. Hospitals*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Specialty Clinics
8.4. Ambulatory Surgical Centers
8.5. Diagnostic Centers
8.6. Others

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.6.1. U.S.
  - 9.2.6.2. Canada
  - 9.2.6.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.6.1. Germany
  - 9.3.6.2. U.K.
  - 9.3.6.3. France
  - 9.3.6.4. Spain
  - 9.3.6.5. Italy
  - 9.3.6.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.6.1. Brazil
  - 9.4.6.2. Argentina
  - 9.4.6.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.6.1. China
  - 9.5.6.2. India
  - 9.5.6.3. Japan
  - 9.5.6.4. South Korea
  - 9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. Becton, Dickinson and Company*
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. KARL STORZ
11.3. Olympus Corporation
11.4. FUJIFILM Holdings Corporation
11.5. Boston Scientific Corporation
11.6. Richard Wolf GmbH
11.7. ATMOS MedizinTechnik GmbH & Co. KG
11.8. LABORIE MEDICAL TECHNOLOGIES CORP.
11.9. EndoMed Systems GmbH
11.10. Entermed

LIST NOT EXHAUSTIVE